Quarterly Result10 Feb 2026, 05:44 pm
JHS Svendgaard Laboratories Ltd. Approves Un-Audited Financial Results for Q3 and Nine Months Ended 31st December, 2025
AI Summary
JHS Svendgaard Laboratories Ltd. has approved the un-audited standalone and consolidated financial results for the quarter and nine months ended 31st December, 2025. The board meeting was held on 10th February, 2026 and the results were prepared in accordance with the Indian Accounting Standards (Ind AS) and other accounting principles generally accepted in India. The company has utilized the funds received for project in Jammu and Kashmir, general corporate purpose, investment in preferential warrants, capital expenditure, and fixed deposits.
Key Highlights
- JHS Svendgaard Laboratories Ltd. approved the un-audited standalone and consolidated financial results for Q3 and nine months ended 31st December, 2025.
- The board meeting was held on 10th February, 2026.
- The results were prepared in accordance with the Indian Accounting Standards (Ind AS) and other accounting principles generally accepted in India.
- The company has utilized the funds received for various purposes including project in Jammu and Kashmir, general corporate purpose, investment in preferential warrants, capital expenditure, and fixed deposits.
Price Impact
More from JHS